Tracxn Technologies IPO

Explore

Sresta Natural Bioproducts IPO

The Hyderabad-based organic food manufacturer Sresta Natural Bioproducts Ltd has submitted preliminary paperwork to SEBI in order to earn about Rs 500 crore through a first share offering. The initial public offering (IPO) consists of a fresh issue of equity shares worth up to Rs 50 crore and an offer-for-sale by the selling shareholders of up to 70.30 lakh equity shares. Peepul Capital Fund III LLC (up to 22.50 lakh shares); Ventureast Life Fund III LLC; Ventureast Trustee Company (on behalf of the Biotechnology Venture Fund and Ventureast Life Fund III); and Ventureast Life Fund III LLC, Ventureast Trustee Company, who together plan to sell nearly 47.80 lakh shares, are the participants in the OFS. The issue's book-running lead managers are JM Financial and Axis Capital.

Opening Date

To be announced

Closing Date

To be announced

Price Band

To be announced

Issue Size

To be announced

Face Value

To be announced

Market Lot

To be announced

Opening Date

To be announced

Closing Date

To be announced

Price Band

To be announced

Issue Size

To be announced

Face Value

To be announced

Market Lot

To be announced

Listing at NSE, BSE

Sresta Natural Bioproducts IPO Important Dates

IPO Open Date To be announced
IPO Close Date To be announced
Allotment Date To be announced
Initiation Of Refunds To be announced
Credit Of Shares To
Demat Account
To be announced
IPO Listing Date To be announced
UPI Mandate Expiry Date To be announced

View all upcoming IPOs

About Sresta Natural Bioproducts

With a market share of 29 per cent in the packaged organic food category in FY 2020, Hyderabad-based Sresta Natural Bioproducts is the owner of the most well-known brand, "24 Mantra." It is in the business of buying, processing, producing, selling, and developing organic food products. With a presence in 39 states across Indian Ethnic Stores and Mainstream, it is also one of the top Indian organic food brands in the USA. By 2021, it will also be present in 34 other countries and on major e-commerce platforms like Bigbasket in India. It provides a wide range of shopping essentials, including packaged food, drinks, meal fixings, spices & condiments, and edible oils. The business cultivates the most land for organic farming among B2C organic food firms in India, and it has close contact with farmers in 12 different states. The business has a network of suppliers that consists of 34,516 farmers, 190,610 acres of certified organic land spread across 12 Indian states, 65 vendors/companies, and several aggregators.

Sresta Natural Bioproducts IPO Objectives

- Funding the working capital requirements of our Company.
- Repayment or pre-payment in full or part, of certain outstanding unsecured/secured borrowings availed by our Company.
- General corporate purposes.

Why should you invest in the Sresta Natural Bioproducts IPO?

  • In Fiscal 2025, the Indian Health and Wellness industry is expected to reach approximately INR 1,27,290 crore, growing at a CAGR of 16% between Fiscal 2020 and Fiscal 2025.
  • Indian packaged food market is expected to contribute 20.2% to the overall food and grocery market by 2030.

Financial Highlights

(in ₹ in Crores, except as otherwise specified)

Particulars FY21 FY20 FY19
Revenue 31.21 26.23 20.55
EBITDA 2.49 2.37 0.62
PAT 1.04 0.95 -0.35
Total Assets 19.36 16.95 15.89
Share Capital 1.83 1.83 1.82
Total Borrowings 5.26 4.45 4.90
Net cash generated from operating activities 2.05 16.49 11.40
Net cash from investing activities -0.13 0.59 -6.71
Net cash flow from financing activities -1.48 -15.28 -8.02
Net change in cash and cash equivalents 0.44 1.79 -3.32

How to apply for Sresta Natural Bioproducts IPO?

UPI & creating a Demat account are the two ways for the investors to start the trading journey. The processes are discussed below:

UPI

  • Link your bank account with the UPI ID.
  • Join your UPI ID to your Demat account.
  • Apply for Sresta Natural Bioproducts IPO and accept the payment request on your UPI ID.

Demat Account

Sresta Natural Bioproducts IPO Noteworthy Highlights:

  • Company’s total income increased at a CAGR of 22.88% from ₹2,082.08 million in Fiscal 2019 to ₹3,143.70 million in Fiscal 2021.
  • As of Fiscal 2021, 52.13% (i.e. ₹1,626.67 million) of company’s total revenue from operations was from domestic markets of which 73% was from the tier I cities in India and 27% was from tier II and tier III cities in India.
  • Sresta Natural Bioproducts are one of the leading Indian organic food brands in the USA with a presence in 39 states across Indian Ethnic Stores and Mainstream Stores (Source: Company Commissioned Industry Report).

The Brand’s Pros & Cons:

Pros Cons
With a varied and innovative product portfolio developed via research & development, the market leader and one of the innovators in India's rapidly expanding organic foods sector. It may have a negative impact if sufficient quantities of organic agricultural products cannot be purchased from growers, aggregators, and organic certified vendors/companies at fair rates or at all.
An omnichannel distribution network supports Pan-India presence and market dominance. The company may suffer if the activities at these third-party facilities are disrupted or if contracts for the first processing of organic raw materials by third-party facilities are terminated.
With exports to 34 nations, one of the top Indian organic food companies in the USA. The inability to properly foresee and successfully adjust to changes in market demand or to satisfy the tastes, preferences, or consistent quality needs of the consumers.
A quality-focused, asset-light strategy with strategically placed processing facilities and complete control over the entire supply chain. India's organic food business is still in its infancy, and because neither farmers nor consumers are aware of the existence of organic food items, they are susceptible to misunderstandings about organic farming.

Competitive Analysis: Market Peers

  24 Mantra Organic India Organic Tattva Conscious Foods Nourish Organics Pro Nature
Fiscal 19 Fiscal 20 Fiscal 19 Fiscal 20 Fiscal 19 Fiscal 20 Fiscal 19 Fiscal 20 Fiscal 19 Fiscal 20 Fiscal 19 Fiscal 20
Revenue (INR Cr) 221.9 273.6 336.1 344.8 69.4 NA 8.4 8.3 5.8 6.8 40.0 53.7
Revenue y-o-y Growth Fiscal 20 vs Fiscal 19 - 23% - 2.60% - NA - -1% - 19.3% - 34.0%
COGS 108.5 138.7 84.2 95.5 44.7 NA 3.4 3.5 2.6 2.6 27.5 36.7
GP 113.4 134.9 251.9 249.4 24.7 NA 5.0 4.8 3.2 4.1 12.5 17.0
GP Margins 51.1% 49.3% 74.9% 72.3% 35.6% NA 59.6% 58.0% 55.3% 60.3% 31.3% 31.7%
EBITDA 15.4 23.9 44.2 28.4 6.2 NA 0.3 0.7 -1.1 -3.5 -0.3 -1.8
EBITDA Margins 6.9% 8.8% 13.2% 8.2% 8.9% NA 3.2% 8.1% -19% -50.74% -0.8% -3.4%
Gross Block 184.3 193.8 442.4 506.6 56.9 NA 2.9 3.7 10.1 10.9 9.6 9.2ss

Sresta Natural Bioproducts IPO FAQs

What is Sresta Natural Bioproducts' Initial Public Offering?

The Sresta Natural Bioproducts IPO comprises a fresh issue of equity shares worth Rs. 50 crore and an Offer for Sale of up to 70.30 lakhs equity shares by the existing shareholders.

When will allotments for the Sresta Natural Bioproducts IPO become available?

Sresta Natural Bioproducts IPO will finalize the allotment by <>.

What will the IPO lot size for Sresta Natural Bioproducts be?

Each Sresta Natural Bioproducts IPO lot has <> shares.

When will Sresta Natural Bioproducts IPO be available to buy?

The IPO of Sresta Natural Bioproducts will be open for subscription from <>.

What is Sresta Natural Bioproducts’ smallest lot size available to retail investors?

The minimum market lot size for the Sresta Natural Bioproducts IPO is <> shares.

Which exchanges will Sresta Natural Bioproducts list on?

Sresta Natural Bioproducts shares will be listed on both BSE as well as the National Stock Exchange (NSE).

What is the IPO size of Sresta Natural Bioproducts?

The IPO size of Sresta Natural Bioproducts is Rs 50 crore.

How to check the allotment status of Sresta Natural Bioproducts IPO on the Angelone App?

The easiest ways to check your IPO allotment status on the Angelone app are below:
  1. Login & Look for Investment Opportunities via Angelone App.
  2. Choose IPOs & FPOs.
  3. Click Order Book.

How will I get my Sresta Natural Bioproducts stock?

Following allotment, the Sresta Natural Bioproducts shares will be credited to the Demat account.

Can I use one PAN to submit multiple applications for the public issue of Sresta Natural Bioproducts?

No, you cannot use the same PAN to make multiple applications for this Sresta Natural Bioproducts IPO or any other public offering.

Is it necessary to give immediate approval to a UPI mandate request?

Yes, immediately approving a UPI mandate request is preferable. Accepting it as soon as you receive it is much better.

Who owns Sresta Natural Bioproducts?

Mr Rajashekar Reddy Seelam is the owner of Sresta Natural Bioproducts.

Enjoy Zero Brokerage on
Equity Delivery

Enjoy Zero Brokerage on Equity Delivery

Get the link to download the App

Send App Link